First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

PURPOSE: Rare cancers are defined by an incidence of <6 out of 100 000 cases per year. They are under-represented in clinical research including tumour molecular analysis. The aim of Arcagen is to generate a multinational database integrating clinical and molecular information of patients with ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Morfouace, Marie, Stevovic, Aleksandra, Vinches, Marie, Golfinopoulos, Vassilis, Jin, Dexter X., Holmes, Oliver, Erlich, Rachel, Fayette, Jerome, Croce, Sabrina, Ray-Coquard, Isabelle, Girard, Nicolas, Blay, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709508/
https://www.ncbi.nlm.nih.gov/pubmed/33262201
http://dx.doi.org/10.1136/esmoopen-2020-001075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709508/
https://www.ncbi.nlm.nih.gov/pubmed/33262201
http://dx.doi.org/10.1136/esmoopen-2020-001075

Ejemplares similares